Germany-based Boehringer Ingelheim has confirmed it is among the companies investing the most in research and production capacity. The company has announced this week a €200m investment to build a new veterinary products manufacturing site in the French region Rhône-Alpes. Construction of the plant will begin as soon as before the end of 2018 and will be completed by the end of 2021. The facility will have an area of 150,000 square meters and will soon create 100 new jobs.
(Source Boehringer Ingelheim)